RICE HALL JAMES & ASSOCIATES, LLC
Position in NBIX — Neurocrine Biosciences Inc
CIK 1230765
San Diego, CA
Position in NBIX
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$16,886,865
+$3,714,183 QoQ
Shares Held
100,195
+0.2% QoQ
Ownership
0.099%
of shares outstanding
% of Portfolio
0.83%
of 13F equity value
Holder Rank
#121
of 768 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 77%
Shared 0%
None 23%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026RICE HALL JAMES & ASSOCIATES, LLC holds $193,433,636 across 12 Drug Manufacturers - Specialty & Generic names. NBIX ranks #6 (8.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
624,928 | $39,964,145 | |
| 2 | PBH |
Prestige Consumer Healthcare Inc.
|
689,692 | $32,601,740 | |
| 3 | BCRX |
Biocryst Pharmaceuticals Inc
|
2,332,043 | $23,320,430 | |
| 4 | SUPN |
Supernus Pharmaceuticals, Inc.
|
490,221 | $22,800,178 | |
| 5 | ALKS |
Alkermes plc.
|
390,866 | $20,481,378 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
This page
|
100,195 | $16,886,865 | |
| 7 | HROW |
Harrow, Inc.
|
387,545 | $16,459,036 | |
| 8 | EOLS |
Evolus, Inc.
|
1,289,888 | $8,951,822 |
All Filings in NBIX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,886,865 | 100,195 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $13,172,682 | 99,990 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $13,902,176 | 98,020 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $13,962,896 | 99,465 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $13,622,533 | 108,382 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $12,129,833 | 109,673 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $15,101,268 | 110,632 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $13,528,786 | 117,417 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $16,259,515 | 118,105 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $17,435,984 | 126,421 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $17,342,382 | 131,621 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $14,873,962 | 132,213 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $12,737,101 | 135,070 | Shares | Sole | 2023-07-24 | |
| 2023-03-31 | $13,891,129 | 137,237 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $17,840,394 | 149,367 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $16,241,526 | 152,919 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $19,744,184 | 202,546 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $19,383,281 | 206,755 | Shares | Sole | 2022-05-26 | |
| 2021-12-31 | $5,959,600 | 69,973 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $7,483,377 | 78,025 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $8,102,473 | 83,256 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $8,098,007 | 83,270 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $8,350,260 | 87,118 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $7,133,148 | 74,180 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $7,934,880 | 65,040 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $5,715,156 | 66,033 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||